Effect of pregnancy on the duration of bovine pericardial bioprostheses

American Heart Journal

Volumn 137, Issue 4 I, 1999, Pages 714-720

  Salazar, E ^a   Espinola, N ^a   Roman, L ^a   Casanova, J M ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; DISEASE CLASSIFICATION; FEMALE; FUNCTIONAL ASSESSMENT; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; INCIDENCE; PREGNANCY; PRIORITY JOURNAL; PROSTHESIS FAILURE; REOPERATION; TREATMENT FAILURE; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

EID: 0032964657     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70228-0     Document Type: Article

References (34)

1. Salazar E, Zajarías A, Gutiérrez N, et al. The problem of cardiac valve prostheses, anticoagulants, and pregnancy. Circulation 1984;70(suppl I):I-169-77.
2. Sareli P, England MJ, Berk MR, et al. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol 1989;63:1462-5.
3. Born D, Martínez EE, Almeida PAM, et al. Pregnancy in patients with prosthetic heart valves: the effects of anticoagulation on mother, fetus, and neonate. Am Heart J 1992;124:413-7.
4. Iturbe-Alessio I, Fonseca MC, Mutchinik O, et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986;315:1390-3.
5. Hanania G, Thomas D, Michel PL, et al. Grossesses chez les porteuses de prothèses valvulaires: Etude cooperative retrospective francaise (155 cas). Arch Mal Coeur 1994;87:429-37.
6. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994;71:196-201.
7. Salazar E, Izaguirre R, Verdejo J, et al. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996;27:1698-703.
8. Nuñez L, Larrea JL, Gil Aguado M, et al. Pregnancy in 20 patients with bioprosthetic valve replacement. Chest 1983;84:26-8.
9. Denbow CE, Matadial L, Sivapragasam S, et al. Pregnancy in patients after homograft cardiac valve replacement. Chest 1983;83:540-1.
10. Deviri E, Levinsky L, Yechezkel M, et al. Pregnancy after valve replacement with porcine xenograft prosthesis. Surg Gynecol Obstet 1985;160:437-43.
11. Matorras R, Reque JA, Usandizaga JA, et al. Prosthetic heart valve and pregnancy: a study of 59 cases. Gynecol Obstet Invest 1985;19:21-31.
12. Cohn LH. Anticoagulation in pregnant women with artificial heart valves [letter to the editor]. N Engl J Med 1987;316:1662-3.
13. Kadri T, Franken RA, Rivetti LA, et al. Protese valvar porcina e gravidez. Arq Bras Cardiol 1989;52:327-31.
14. Ayhan A, Yapar EG, Kisnisci HA, et al. Pregnancy and its complications after cardiac valve replacement. Int J Gynecol Obstet 1991;35:117-22.
15. Badduke BR, Jamieson WRE, Miyagishima RT, et al. Pregnancy and childbearing in a population with biologic valvular prostheses. J Thorac Cardiovasc Surg 1991;102:179-86.
16. Jamieson WRE, Miller DC, Akins CW, et al. Pregnancy and bioprostheses: influence on structural valve deterioration. Ann Thorac Surg 1995;60:S282-7.
17. Bortolotti U, Milano A, Mazzuco A, et al. Pregnancy in patients with a porcine valve bioprosthesis. Am J Cardiol 1982;50:1051-4.
18. Ginsberg JS, Barrón WM. Pregnancy and prosthetic heart valves. Lancet 1994;344:1170-2.
19. Oakley CM. Pregnancy and prosthetic heart valves. Lancet 1994; 344:1643-4.
20. Oakley CM. Anticoagulants in pregnancy. Br Heart J 1995;74:107-11.
21. Elkayam U. Anticoagulation in pregnant women with prosthetic heart valves: a double jeopardy. J Am Coll Cardiol 1996;27:1704-6.
22. Fernández de la Reguera G, Alzaga MT, Cabrera J, et al. Manufactura de prótesis valvulares de pericardio bovino, su valoración y resultados iniciales del primer grupo de implante. Arch Inst Cardiol Mex 1984;54:333-44.
23. Fernández de la Reguera G, Barragán-García R, Alzaga MT, et al. Evolución a largo plazo de mil pacientes con reemplazo valvular con prótesis "Instituto Nacional de Cardiología Ignacio Chávez." Arch Inst Cardiol Mex 1992;62:513-20.
24. Sebening F, Schroll A. Pericardial bioprostheses: an overview. In: Piwnica A, Westaby S, editors. Stentless bioprostheses. Oxford, UK: Isis Medical Media; 1995. p 36-9.
25. Edmunds LH, Clark RE, Cohn LH, et al. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg 1988;96:351-3.
26. GB-STAT for Windows Version 6.0. 1st ed. Dynamic Microsystems, Inc. Silver Spring, Md. 1994.
27. Grunkemeier GL, Starr A, Rahimtoola SH. Prosthetic heart valve performance: long-term follow-up. Curr Probl Cardiol 1992;17:331-406.
28. Master RG, Wiley VM, Pipe L, et al. Long-term experience with the Ionescu-Shiley pericardial valve. Ann Thorac Surg 1995;60:S288-91.
29. Mazzucotelli JP, Bertrand PC, Loisance DY. Durability of the Mitroflow pericardial valve at ten years. Ann Thorac Surg 1995;60:S303-4.
30. Jamieson WRE, Rosado LJ, Munro AI, et al. Carpentier-Edwards standard porcine bioprosthesis: primary tissue failure (structural valve deterioration) by age groups. Ann Thorac Surg 1988;46:155-62.
31. Pelletier LC, Carrier M, Leclerc Y, et al. Influence of age on late results of valve replacement with porcine bioprostheses. J Cardiovasc Surg 1992;33:526-33.
32. Pelletier LC, Carrier M, Leclerc Y, et al. The Carpentier-Edwards pericardial bioprosthesis: clinical experience with 600 patients. Ann Thorac Surg 1995;60:S297-302.
33. Pomar JL, Jamieson WRE, Pelletier LC, et al. Mitroflow pericardial bioprosthesis: clinical performance to ten years. Ann Thorac Surg 1995;60:S305-10.
34. Oakley C. Valve prostheses and pregnancy. Br Heart J 1987;54:303-5